IL-33/s-ST2 ratio, systemic symptoms, and basophil activation in Pru p 3-sensitized allergic patients.
Carina G UasufCaterina Di SanoSebastiano GangemiGiuseppe AlbeggianiDiego CignaPaola DinoIgnazio BruscaMark GjomarkajElisabetta PacePublished in: Inflammation research : official journal of the European Histamine Research Society ... [et al.] (2018)
An imbalance in the baseline levels of IL-33/ST2 pathway is present in Pru p 3-SAP. The measurement of this pathway might be helpful to detect patients at a higher risk of developing severe systemic symptoms.